Covid-19: FDA authorises neutralising antibody bamlanivimab for non-admitted patients
- PMID: 33177042
- DOI: 10.1136/bmj.m4362
Covid-19: FDA authorises neutralising antibody bamlanivimab for non-admitted patients
LinkOut - more resources
Full Text Sources